INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Robotics And Automation Addressing Production Shortages For Compounding Pharmacies
Drug shortages have increased the burden on compounding pharmacies. Robotics and automation can streamline processes, improve accuracy, and ensure quality to address challenges faced by these facilities.
-
Accountability For The Whole PFS System
When component suppliers only own their part, system-level performance becomes your responsibility. And if something fails, accountability disappears into the gaps.
-
Formulation Development For Therapeutic Oligonucleotides
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
Product-Wet Integrity Testing: Risk-Based Strategies
When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.
-
Managing Volatility, Complexity, And Risk In Injectable Manufacturing5/26/2026
Modern injectables raise sterile fill–finish complexity and risk, making capacity, yield protection, integrated analytics, and supply‑chain resilience essential from development to commercial launch.
-
Lyophilization To Enable Drug Products Containing Labile Molecules6/6/2025
Develop lyophilized formulations to overcome stability challenges and significantly extend the shelf life of sensitive therapeutic products.
-
A State-Of-The-Art Syringe Liquid Sampler6/24/2025
Discover a cutting-edge syringe liquid sampler for Life Sciences that offers USP <788> compliance, versatile syringe compatibility, and advanced features for precise particulate testing.
-
What Is Aseptic Processing?1/9/2026
Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this method ensures safety, extends shelf life, and protects medicines from contamination.
-
USP <788> Revisions And Why Packaging Matters More Than Ever5/12/2026
Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
A global partner offering prefillable drug‑delivery systems, manufacturing expertise, and integrated services that accelerate development, secure supply, and support therapies across multiple areas.
-
Leverage a pre-verified, integrated syringe platform. Accelerate timelines and reduce costs by eliminating drug-independent testing while streamlining regulatory submissions through one source.
-
Used 300 sq ft BOC Edward freeze dryer, model LYOMAX 28, 316L stainless steel product contact surfaces with (13) 1170 mm wide x 1850 mm deep usable shelves, 115 mm shelf spacing, stoppering, external condenser with 300 kg ice capacity, refrigeration and vacuum skid with liquid natural gas refrigeration, model AV-LUS BOC Edward loading / unloading skid, 480 volt with controls, freeze dryer serial# MTE1930, built 2004.
-
- Advanced Technology
- Laboratory, stability/clinical trial, 503b, vaccine, biologic, small scale production capable Blow/Fill/Seal system
- Extremely versatile, small-footprint machine
- Single-Use Technology (SUT) or CIP/SIP configuration
- All Electric-Servo motion controls
- Stepped-base design for easy maintenance and changeover
-
A next‑generation injectable system uses shorter, thinner needles to reduce injection risk, lower force and time requirements, and improve comfort and usability for administering viscous formulations.